Common Wellbutrin side effects may include: dry mouth, sore throat, stuffy nose; ringing in the ears; Feb 1, 2024 · Check with your doctor right away if you have blistering, peeling, or loosening of the skin, red skin lesions, severe acne or a skin rash, sores or ulcers on the skin, or fever or chills with this medicine
4 out of 10 from a total of 43 reviews for the off-label treatment of Weight Loss (Obesity/Overweight)
BUPROPION; NALTREXONE (byoo PROE pee on; nal TREX one) is a combination of
Side Effects Drug information provided by: Merative, Micromedex ® Along
1
Contrave is an anorexiant and is used to help manage weight in obese or
Card savings are subject to a maximum
At week 52, no fluctuations in weight were found in the placebo group compared with baseline (+0
Dry mouth, sore throat, dizziness, nausea, vomiting, ringing in the ears, headache, decreased appetite, weight loss, constipation, trouble sleeping, increased sweating, or shaking (tremor) may People taking bupropion should be monitored for the appearance of neuropsychiatric symptoms
Bupropion is used to treat depression and to prevent depression in patients with seasonal affective disorder (SAD), which is sometimes called winter depression
In the US - Call your doctor for medical advice about side effects
, severe head A higher proportion of subjects in the bupropion group (23%) had a weight loss ≥5 lbs
Sustained-release (SR), film-coated bupropion hydrochloride tablets (e
A weight loss of greater than 5 lbs occurred in 28% of subjects receiving bupropion hydrochloride tablets
Call your doctor for medical advice about side effects
If weight loss is a major presenting sign of a patient’s depressive illness, the anorectic and/or weight-reducing potential of bupropion hydrochloride extended-release tablets (SR) should be considered
therapeutic dosing are nonspecific and may include dry mouth, constipation, headache, nausea, agitation, insomnia, and weight loss
Bupropion hydrochloride extended-release (SR) tablets 300 mg/day (n = 339) Bupropion hydrochloride extended-release (SR) compared with 9% of subjects treated with the immediate-release formulation of bupropion